Zynex (ZYXI) Competitors $1.64 -0.04 (-2.38%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$1.67 +0.03 (+1.77%) As of 08/28/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZYXI vs. CVRX, CV, TLSI, ELMD, BSGM, LNSR, RCEL, AVR, LAKE, and MBOTShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include CVRx (CVRX), CapsoVision (CV), TriSalus Life Sciences (TLSI), Electromed (ELMD), Biosig Technologies (BSGM), LENSAR (LNSR), Avita Medical (RCEL), Anteris Technologies Global (AVR), Lakeland Industries (LAKE), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry. Zynex vs. Its Competitors CVRx CapsoVision TriSalus Life Sciences Electromed Biosig Technologies LENSAR Avita Medical Anteris Technologies Global Lakeland Industries Microbot Medical Zynex (NASDAQ:ZYXI) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership. Is ZYXI or CVRX more profitable? Zynex has a net margin of -19.79% compared to CVRx's net margin of -95.61%. Zynex's return on equity of -78.54% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets Zynex-19.79% -78.54% -16.70% CVRx -95.61%-79.31%-40.96% Does the media refer more to ZYXI or CVRX? In the previous week, Zynex and Zynex both had 1 articles in the media. Zynex's average media sentiment score of 1.87 equaled CVRx'saverage media sentiment score. Company Overall Sentiment Zynex Very Positive CVRx Very Positive Which has preferable valuation and earnings, ZYXI or CVRX? Zynex has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZynex$192.35M0.26$2.99M-$0.94-1.74CVRx$51.29M4.02-$59.97M-$2.10-3.75 Do insiders & institutionals hold more shares of ZYXI or CVRX? 29.7% of Zynex shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 49.3% of Zynex shares are held by insiders. Comparatively, 13.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts rate ZYXI or CVRX? Zynex currently has a consensus target price of $4.90, suggesting a potential upside of 198.78%. CVRx has a consensus target price of $14.00, suggesting a potential upside of 77.66%. Given Zynex's higher probable upside, equities research analysts clearly believe Zynex is more favorable than CVRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33CVRx 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86 Which has more risk & volatility, ZYXI or CVRX? Zynex has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, CVRx has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. SummaryZynex beats CVRx on 9 of the 15 factors compared between the two stocks. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$50.90M$10.89B$5.78B$9.79BDividend YieldN/A1.87%3.95%4.02%P/E Ratio-1.7421.3931.2626.59Price / Sales0.2629.99453.73167.91Price / Cash6.8824.7837.7359.36Price / Book41.003.5110.046.68Net Income$2.99M$210.11M$3.27B$265.59M7 Day Performance-1.20%2.14%1.34%0.66%1 Month Performance-33.87%14.27%6.13%2.64%1 Year Performance-79.45%-7.07%41.90%22.36% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex2.8197 of 5 stars$1.64-2.4%$4.90+198.8%-79.3%$50.90M$192.35M-1.74770Positive NewsCVRXCVRx2.5419 of 5 stars$6.87-2.3%$14.00+103.8%-20.6%$183.85M$51.29M-3.27160Positive NewsCVCapsoVisionN/A$4.00+3.9%$5.50+37.5%N/A$178.43MN/A0.0090TLSITriSalus Life Sciences3.1815 of 5 stars$4.86+6.8%$10.75+121.2%+2.4%$172.17M$29.43M-4.12106ELMDElectromed2.3576 of 5 stars$19.69+4.0%$33.50+70.1%+61.8%$165.12M$61.44M26.25160Trending NewsAnalyst ForecastAnalyst RevisionBSGMBiosig Technologies2.2526 of 5 stars$5.48+10.3%$10.00+82.5%+1,130.0%$156.15M$40K0.0050High Trading VolumeLNSRLENSAR1.0562 of 5 stars$12.75+0.8%$15.00+17.6%+160.2%$150.98M$53.49M-3.03110Positive NewsRCELAvita Medical1.5663 of 5 stars$5.55-1.4%$12.40+123.4%-51.9%$149.87M$64.25M-2.82130AVRAnteris Technologies Global1.8838 of 5 stars$3.80-5.9%$16.50+334.2%N/A$145.69M$2.70M0.00138LAKELakeland Industries4.5852 of 5 stars$15.06+0.6%$26.00+72.6%-34.9%$142.43M$167.21M-5.002,100News CoveragePositive NewsUpcoming EarningsMBOTMicrobot Medical1.5396 of 5 stars$3.08-0.3%$9.00+192.2%+322.3%$140.74MN/A-5.3120Gap Up Related Companies and Tools Related Companies CVRx Alternatives CapsoVision Alternatives TriSalus Life Sciences Alternatives Electromed Alternatives Biosig Technologies Alternatives LENSAR Alternatives Avita Medical Alternatives Anteris Technologies Global Alternatives Lakeland Industries Alternatives Microbot Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZYXI) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.